routes

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Source Node:
Time Stamp: September 20, 2023 8:35 AM - Modified On: September 20, 2023 - Published By:
Source Cluster:
Republished By Plato

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

Drawing Parallels

Source Node:
Time Stamp: October 26, 2022 5:36 AM - Modified On: October 26, 2022 - Published By:
Source Cluster:
Republished By Plato

For many people in crypto, the way that regulators are approaching the industry is unique and can at times seem unnecessarily adversarial. For those with prior experience in nascent industries, it bears remarkable similarities to how other technologies have seen regulations imposed on them. For many people in crypto, the way that regulators are approaching the industry is unique and can at times seem unnecessarily adversarial. For those with prior experience in nascent industries, it bears remarkable similarities to how other technologies have seen regulations imposed on them. Five years